| Date Filed | Type | Description |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2021 |
4
| Murphy Polly A. (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Bought 12,000 shares
@ $8.5663, valued at
$102.8k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Lucidi Bruno (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 34,025 options to buy
@ $23.39, valued at
$795.8k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Murphy Polly A. (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 34,025 options to buy
@ $23.39, valued at
$795.8k
|
|
| 05/20/2021 |
4
| Adams Jerome M. (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 56,670 options to buy
@ $23.43, valued at
$1.3M
|
|
| 05/20/2021 |
3
| Adams Jerome M. (Director) has filed a Form 3 on Atea Pharmaceuticals, Inc. |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Foster Wayne (See Remarks) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Granted 71,750 options to buy
@ $73, valued at
$5.2M
|
|
| 11/05/2020 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Atea Pharmaceuticals, Inc.|
Txns:
| Converted 6,411,355 shares
@ $0
Converted 1,000,000 convertible preferred
@ $0
Converted 1,650,165 convertible preferred
@ $0
Converted 2,631,580 convertible preferred
@ $0
Converted 712,250 convertible preferred
@ $0
Converted 417,360 convertible preferred
@ $0 |
|
|